Appeals court revives antitrust claims against Align
The October 5, 2026 ruling reopens litigation over clear aligners and could heighten legal and market pressure on Align Technology.
Mateo Fernandez ·
Align Technology lost a legal win on October 5, 2026 as an appeals court revived antitrust claims over its dental aligners, risking renewed litigation and damages.
Market reaction was pending at the US close.
Officials said the appeals court revived claims alleging anticompetitive conduct in the clear-aligner market.
Antitrust claims against aligners
If plaintiffs press the case and win remedies, then Align could face damages, higher legal costs and limits on certain commercial arrangements that affect sales and distribution. The practical impact will depend on how expansive any court remedy is and whether the case returns to trial.
The ruling also creates an immediate governance and disclosure issue for investors. If litigation risk is re-evaluated, analysts and portfolio managers may adjust revenue and margin assumptions for Align and for peers in the dental-device segment, which could affect equity valuations across the group.
Watch for a company statement or an updated court filing by October 8, 2026; those filings are likely to contain the clearest signals on how the litigation will proceed and what the near-term market implications might be.